Proteasome_NP Regulates_NP the_DT Delivery_NN of_IN LDL_NP Receptor-related_NP Protein_NP into_IN the_DT Degradation_NP Pathway_NP The_DT low-density_NN lipoprotein_NN receptor_NN (LDLR)-related_JJ protein_NN (_( LRP_NP )_) is_VBZ a_DT multiligand_NN endocytic_JJ receptor_NN that_WDT has_VBZ broad_JJ cellular_JJ and_CC physiological_JJ functions_NNS ._SENT Previous_JJ studies_NNS have_VBP shown_VBN that_IN both_DT tyrosine-based_JJ and_CC di-leucine_JJ motifs_NNS within_IN the_DT LRP_NP cytoplasmic_JJ tail_NN are_VBP responsible_JJ for_IN mediating_VBG its_PP$ rapid_JJ endocytosis_NN ._SENT Little_RB is_VBZ known_VBN ,_, however_RB ,_, about_IN the_DT mechanism_NN by_IN which_WDT LRP_NP is_VBZ targeted_VBN for_IN degradation_NN ._SENT By_IN examining_VBG both_DT endogenous_JJ full-length_NN and_CC a_DT minireceptor_NN form_NN of_IN LRP_NP ,_, we_PP found_VBD that_IN proteasomal_JJ inhibitors_NNS ,_, MG132_NP and_CC lactacystin_NP ,_, prolong_VBP the_DT cellular_JJ half-life_NN of_IN LRP_NP ._SENT The_DT presence_NN of_IN proteasomal_JJ inhibitors_NNS also_RB significantly_RB increased_VBN the_DT level_NN of_IN LRP_NP at_IN the_DT cell_NN surface_NN ,_, suggesting_VBG that_IN the_DT delivery_NN of_IN LRP_NP to_TO the_DT degradation_NN pathway_NN was_VBD blocked_VBN at_IN a_DT compartment_NN from_IN which_WDT recycling_NN of_IN the_DT receptor_NN to_TO the_DT cell_NN surface_NN still_RB occurred_VBD ._SENT Immunoelectron_NP microscopy_NN analyses_NNS demonstrated_VBD a_DT proteasomal_JJ inhibitor-dependent_JJ reduction_NN in_IN LRP_NP minireceptor_NN within_IN both_DT limiting_VBG membrane_NN and_CC internal_JJ vesicles_NNS of_IN the_DT multivesicular_JJ bodies_NNS ,_, which_WDT are_VBP compartments_NNS that_WDT lead_VBP to_TO receptor_NN degradation_NN ._SENT In_IN contrast_NN to_TO the_DT growth_NN hormone_NN receptor_NN ,_, we_PP found_VBD that_IN the_DT initial_JJ endocytosis_NN of_IN LRP_NP minireceptor_NN does_VBZ not_RB require_VB a_DT functional_JJ ubiquitin_NN --_: proteasome_JJ system_NN ._SENT Finally_RB ,_, using_VBG truncated_JJ cytoplasmic_JJ mutants_NNS of_IN LRP_NP minireceptors_NNS ,_, we_PP found_VBD that_IN a_DT region_NN of_IN 19_CD amino_NN acids_NNS within_IN the_DT LRP_NP tail_NN is_VBZ required_VBN for_IN proteasomal_JJ regulation_NN ._SENT Taken_VBN together_RB our_PP$ results_NNS provide_VBP strong_JJ evidence_NN that_IN the_DT cellular_JJ turnover_NN of_IN a_DT cargo_NN receptor_NN ,_, i.e._FW ,_, LRP_NP ,_, is_VBZ regulated_VBN by_IN the_DT proteasomal_JJ system_NN ,_, suggesting_VBG a_DT broader_JJR function_NN of_IN the_DT proteasome_NN in_IN regulating_VBG the_DT trafficking_NN of_IN receptors_NNS into_IN the_DT degradation_NN pathway_NN ._SENT The_DT low-density_NN lipoprotein_NN receptor_NN (LDLR)-related_JJ protein_NN (_( LRP_NP )_) is_VBZ a_DT large_JJ endocytic_JJ receptor_NN that_WDT belongs_VBZ to_TO the_DT emerging_VBG LDLR_NP family_NN ._SENT LRP_NP is_VBZ a_DT unique_JJ receptor_NN in_IN the_DT family_NN because_IN of_IN its_PP$ ability_NN to_TO bind_NN and_CC endocytose_NN a_DT variety_NN of_IN structurally_RB and_CC functionally_RB distinct_JJ ligands_NNS and_CC its_PP$ important_JJ role_NN during_IN embryonic_JJ development_NN and_CC the_DT pathogenesis_NN of_IN various_JJ diseases_NNS (_( reviewed_VBN in_IN ;_: ;_: ;_: )_) ._SENT Ligands_NNS of_IN LRP_NP include_VBP proteins_NNS that_WDT are_VBP involved_VBN in_IN lipid_NN metabolism_NN ,_, proteinase_NN regulation_NN ,_, blood_NN coagulation/fibrinolysis_NN cascades_NNS ,_, and_CC several_JJ membrane_NN proteins_NNS ,_, including_VBG urokinase_NP plasminogen_NP activator_NN receptor_NN (_( uPAR_NN )_) and_CC beta-amyloid_JJ precursor_NN protein_NN (_( APP_NP )_) ._SENT LRP_NP 's_POS extracellular_JJ domain_NN contains_VBZ 31_CD ligand-binding_NN repeats_NNS grouped_VBN into_IN four_CD clusters_NNS of_IN 2_CD ,_, 8_CD ,_, 10_CD ,_, and_CC 11_CD repeats_NNS ,_, respectively_RB ._SENT However_RB ,_, only_RB the_DT second_JJ and_CC the_DT fourth_JJ clusters_NNS have_VBP been_VBN shown_VBN to_TO mediate_VB ligand_NN binding_NN ._SENT The_DT extracellular_JJ domain_NN of_IN LRP_NP precedes_VBZ a_DT single_JJ membrane-spanning_NN segment_NN ,_, which_WDT is_VBZ followed_VBN by_IN a_DT 100-amino_NP acid_JJ cytoplasmic_JJ tail_NN ._SENT Biochemical_JJ studies_NNS have_VBP shown_VBN that_IN LRP_NP is_VBZ synthesized_VBN as_IN a_DT single_JJ polypeptide_NN chain_NN of_IN similar600_JJ kDa_NN that_WDT is_VBZ cleaved_VBN by_IN furin_NN in_IN the_DT trans-Golgi_NN compartments_NNS into_IN two_CD subunits_NN of_IN 515_CD and_CC 85_CD kDa_NNS ,_, which_WDT remain_VBP associated_VBN noncovalently_RB with_IN one_CD another_DT as_IN they_PP mature_VBP to_TO the_DT cell_NN surface_NN ._SENT Another_DT significant_JJ feature_NN of_IN LRP_NP is_VBZ its_PP$ rapid_JJ endocytosis_NN when_WRB compared_VBN with_IN that_DT of_IN other_JJ members_NNS of_IN the_DT LDLR_NP family_NN ._SENT Although_IN two_CD copies_NNS of_IN the_DT NPxY_NP motif_NN ,_, which_WDT has_VBZ been_VBN shown_VBN to_TO mediate_VB LDLR_NP endocytosis_NN ,_, are_VBP present_JJ within_IN the_DT LRP_NP tail_NN ,_, recent_JJ studies_NNS from_IN our_PP$ laboratory_NN have_VBP shown_VBN that_IN the_DT primary_JJ endocytosis_NN signals_NNS for_IN LRP_NP are_VBP a_DT YxxL_NP motif_NN and_CC a_DT di-leucine_NN motif_NN ._SENT Our_PP$ studies_NNS have_VBP also_RB shown_VBN that_IN the_DT initial_JJ endocytosis_NN of_IN LRP_NP is_VBZ further_RBR regulated_VBN by_IN cyclic_JJ AMP_NNS --_: dependent_JJ protein_NN kinase_NN A_NP (_( PKA_NP )_) phosphorylation_NN on_IN a_DT serine_NN residue_NN within_IN LRP_NP 's_POS cytoplasmic_JJ tail_NN ._SENT These_DT studies_NNS together_RB indicate_VBP that_IN the_DT endocytic_JJ trafficking_NN of_IN LRP_NP is_VBZ unique_JJ compared_VBN with_IN other_JJ LDLR_NP family_NN members_NNS ._SENT Previous_JJ studies_NNS on_IN LRP_NP trafficking_NN have_VBP focused_VBN on_IN the_DT early_JJ secretory_JJ pathway_NN and_CC the_DT early_JJ events_NNS of_IN endocytosis_NN ._SENT However_RB ,_, little_RB is_VBZ known_VBN regarding_VBG the_DT trafficking_NN of_IN LRP_NP to_TO the_DT degradation_NN pathway_NN ._SENT The_DT ubiquitin_NN --_: proteasome_JJ system_NN plays_VBZ an_DT important_JJ role_NN in_IN mediating_VBG both_DT receptor_NN endocytosis_NN and_CC sorting_VBG to_TO the_DT degradation_NN pathway_NN for_IN several_JJ cell_NN surface_NN receptors_NNS ._SENT Although_IN polyubiquitination_NN of_IN proteins_NNS leads_VBZ to_TO their_PP$ degradation_NN via_IN the_DT 26S_JJ proteasome_NN ,_, monoubiquitination_NN has_VBZ recently_RB been_VBN shown_VBN to_TO modulate_VB the_DT function_NN and_CC trafficking_NN of_IN various_JJ cellular_JJ proteins_NNS ._SENT To_TO date_VB the_DT most_RBS definitively_RB studied_VBN examples_NNS of_IN the_DT involvement_NN of_IN the_DT ubiquitin_NN --_: proteasome_JJ regulation_NN of_IN cell_NN surface_NN receptor_NN include_VBP the_DT yeast_NN G_NN protein-coupled_JJ receptors_NNS ,_, the_DT growth_NN hormone_NN receptor_NN (_( GHR_NP ;_: ;_: )_) ,_, the_DT human_JJ epidermal_JJ growth_NN factor_NN receptor_NN (_( EGFR_NP ;_: ;_: ;_: )_) and_CC the_DT mammalian_JJ beta2-adrenergic_JJ receptor_NN ._SENT In_IN case_NN of_IN the_DT GHR_NN ,_, it_PP was_VBD found_VBN that_IN although_IN ubiquitination_NN of_IN GHR_NP itself_PP is_VBZ not_RB required_JJ ,_, functional_JJ ubiquitination_NN and_CC proteasomal_JJ systems_NNS are_VBP both_DT essential_JJ for_IN its_PP$ endocytosis_NN and_CC trafficking_NN to_TO the_DT degradation_NN pathway_NN ._SENT Despite_IN recent_JJ evidence_NN for_IN the_DT engagement_NN of_IN LRP_NP in_IN several_JJ signal_NN transduction_NN pathways_NNS ,_, the_DT multiple_JJ ligands_NNS for_IN and_CC rapid_JJ endocytosis_NN rate_NN of_IN LRP_NP suggest_VBP that_IN a_DT major_JJ function_NN of_IN this_DT receptor_NN is_VBZ the_DT cellular_JJ transport_NN of_IN ligands_NNS via_IN receptor-mediated_JJ endocytosis_NN ._SENT To_TO examine_VB whether_IN the_DT transport_NN of_IN such_PDT a_DT signal_NN transducing/cargo_NN receptor_NN is_VBZ regulated_VBN by_IN the_DT ubiquitin_NN --_: proteasome_JJ system_NN ,_, we_PP analyzed_VBD the_DT effects_NNS of_IN proteasomal_JJ inhibitors_NNS on_IN the_DT endocytic_JJ trafficking_NN and_CC cellular_JJ turnover_NN of_IN LRP_NP ._SENT We_PP found_VBD that_IN the_DT delivery_NN of_IN LRP_NP to_TO the_DT degradation_NN pathway_NN is_VBZ blocked_VBN within_IN a_DT compartment_NN from_IN which_WDT recycling_NN of_IN the_DT receptor_NN still_RB occurs_VBZ ._SENT Materials_NNS |_SYM Recombinant_JJ human_JJ RAP_NN was_VBD produced_VBN as_IN a_DT glutathione_NN S-transferase_NN fusion_NN protein_NN and_CC purified_VBD as_RB described_VBN before_RB ._SENT All_DT tissue_NN culture_NN media_NNS ,_, sera_NN ,_, and_CC plastic_JJ supplies_NNS were_VBD from_IN Life_NP Technologies_NPS (_( Grand_NP Island_NP ,_, NY_NP )_) ._SENT Na125I_NP was_VBD purchased_VBN from_IN NEN_NP Life_NP Sciences_NPS (_( Boston_NP ,_, MA_NP )_) ._SENT [_SYM 35S]Cysteine_JJ was_VBD from_IN ICN_NP (_( Costa_NP Mesa_NP ,_, CA_NP )_) ._SENT IODO-GEN_NP reagent_NN was_VBD from_IN Pierce_NP (_( Rockford_NP ,_, IL_NP )_) ._SENT MG132_NP (_( Z-Leu-leu-leu-H_NP aldehyde_NN )_) proteasomal_JJ inhibitor_NN was_VBD from_IN Peptide_NP Institute_NP ,_, Inc_NP (_( Minosh-shi_NP Osaka_NP ,_, Japan_NP )_) ._SENT Clasto-lactacystin-beta-lactone_NP (_( referred_VBN to_TO as_IN lactacystin_NN in_IN this_DT manuscript_NN )_) proteasomal_JJ inhibitor_NN was_VBD from_IN Calbiochem-Novabiochem_NP (_( La_NP Jolla_NP ,_, CA_NP )_) ._SENT Complete_JJ protease_NN inhibitor_NN cocktail_NN (_( Complete_JJ )_) was_VBD from_IN Roche_NP (_( Indianapolis_NP ,_, IN_IN )_) ._SENT Mouse_NP anti-HA_NP antibody_NN was_VBD from_IN Babco_NP (_( 12CA5_NP ;_: Richmond_NP ,_, CA_NP )_) ._SENT FITC-conjugated_JJ goat_NN anti-mouse_NN antibody_NN was_VBD from_IN BD_NP Biosciences-PharMingen_NP (_( San_NP Diego_NP ,_, CA_NP )_) ._SENT Horseradish_NN peroxidase_NN --_: linked_VBN anti-mouse_NN antibody_NN ,_, ECL_NP detection_NN system_NN ,_, and_CC Rainbow_NP molecular_JJ size_NN markers_NNS were_VBD from_IN Amersham_NP Pharmacia_NP Biotech_NP (_( Piscataway_NP ,_, NJ_NP )_) ._SENT All_DT other_JJ chemicals_NNS were_VBD reagent_NN grade_NN and_CC from_IN Sigma_NP (_( St._NP Louis_NP ,_, MO_NP )_) ._SENT Cell_NN Culture_NP |_SYM Human_JJ hepatoma_NN HepG2_NN cells_NNS were_VBD cultured_VBN in_IN minimum_JJ essential_JJ medium_NN (_( MEM_NP )_) supplemented_VBD with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, 100_CD U/ml_NP penicillin_NN ,_, 100_CD mug/ml_NN streptomycin_NN ,_, and_CC 300_CD mug/ml_NN l-glutamine_NN ._SENT Chinese_JJ hamster_NN ovary_NN (CHO)-K1_NN and_CC CHO_NP LRP-null_NP cells_NNS were_VBD cultured_VBN in_IN F-12_NP Ham_NP 's_POS media_NNS with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, 100_CD U/ml_NP penicillin_NN ,_, 100_CD mug/ml_NN streptomycin_NN ,_, and_CC 300_CD mug/ml_NN l-glutamine_NN ._SENT Ts20_NN cells_NNS were_VBD grown_VBN in_IN MEMalpha_NP supplemented_VBD with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ,_, 4.5_CD g/l_NN glucose_NN ,_, 100_CD U/ml_NP penicillin_NN ,_, and_CC 100_CD mug/ml_NN streptomycin_NN ._SENT CHO-mLRP4_NP ,_, ts20-mLRP4_NN ,_, and_CC ts20-GHR_NN cells_NNS were_VBD cultured_VBN under_IN the_DT same_JJ conditions_NNS as_IN their_PP$ parent_JJ CHO_NP cells_NNS ,_, except_IN with_IN the_DT addition_NN of_IN 350_CD mug/ml_NN (_( for_IN CHO-mLRP4_NP cells_NNS )_) or_CC 450_CD mug/ml_NN (_( for_IN ts20-mLRP4_NN and_CC ts20-GHR_NN cells_NNS )_) geneticin_NN ._SENT Ts20_NN cells_NNS were_VBD maintained_VBN at_IN 30C_JJ ;_: all_DT others_NNS were_VBD maintained_VBN at_IN 37C_JJ in_IN a_DT humidified_VBN incubator_NN with_IN 5_CD %_NN CO2_NN ._SENT Metabolic_JJ Pulse-chase_NP Labeling_NP and_CC Immunoprecipitation_NP |_SYM HepG2_NP ,_, CHO-K1_NP ,_, or_CC CHO-mLRP4_NP cells_NNS were_VBD seeded_VBN at_IN 5_CD x_SYM 105_CD cells/well_NN density_NN in_IN six-well_NN plates_NNS and_CC cultured_VBN overnight_RB before_IN experiments_NNS ._SENT HepG2_JJ cells_NNS transiently_RB transfected_VBN with_IN mLRP4_NN by_IN calcium_NN phosphate_NN method_NN were_VBD replated_VBN after_IN overnight_JJ transfection_NN and_CC cultured_VBN for_IN an_DT additional_JJ 24_CD h_NN before_IN experiments_NNS ._SENT Metabolic_JJ pulse-chase_NN labeling_VBG of_IN LRP_NP or_CC mLRP4_JJ with_IN [_SYM 35S]cysteine_JJ was_VBD performed_VBN essentially_RB as_RB described_VBN before_RB ._SENT Briefly_RB ,_, after_IN depletion_NN of_IN endogenous_JJ cysteine_NN ,_, cells_NNS were_VBD pulse-labeled_VBN with_IN [_SYM 35S]cysteine_JJ (_( 200_CD muCi/ml_NN )_) in_IN cysteine-free_JJ MEM_NP and_CC chased_VBD with_IN serum-containing_VBG medium_NN in_IN the_DT presence_NN or_CC absence_NN of_IN 20_CD muM_NN MG132_NN for_IN various_JJ times_NNS as_RB indicated_VBD in_IN each_DT experiment_NN ._SENT Cells_NNS were_VBD then_RB lysed_VBN at_IN 4C_JJ in_IN 0.5_CD ml_NN PBSc_NP (_( phosphate-buffered_JJ saline_NN supplemented_VBN with_IN 1_CD mM_NP CaCl2_NP and_CC 0.5_CD mM_NP MgCl2_NP )_) containing_VBG 1_CD %_NN Triton_NP X-100_NP ,_, 1_CD mM_NP PMSF_NP ,_, 1x_NP Complete_JJ ,_, and_CC 10_CD mM_NP N-ethymaleimide_NP (_( NEM_NP ;_: lysis_NN buffer_NN )_) ._SENT Cell_NN lysates_NNS were_VBD incubated_VBN with_IN an_DT excess_NN of_IN either_DT anti-LRP_NP antibody_NN (_( for_IN endogenous_JJ LRP_NP with_IN HepG2_NP cells_NNS )_) or_CC monoclonal_NN anti-HA_NN antibody_NN (_( for_IN mLRP4_NN with_IN CHO-mLRP4_NP cells_NNS )_) ,_, followed_VBN with_IN protein-A_NN agarose_NN beads_NNS ._SENT Immunoprecipitated_JJ protein_NN was_VBD released_VBN from_IN the_DT beads_NNS by_IN boiling_VBG in_IN Laemmli_NP sample_NN buffer_NN under_IN reducing_VBG conditions_NNS and_CC analyzed_VBN via_IN SDS-PAGE_NP ._SENT Band_NN intensities_NNS were_VBD quantitated_VBN using_VBG a_DT phosphoimager_NN (_( Storm_NP 840_CD ;_: Molecular_NP Dynamics_NPS ,_, Sunnyvale_NP ,_, CA_NP )_) ._SENT Western_NP Blotting_NP of_IN LRP_NP Minireceptor_NP |_SYM CHO-mLRP4_JJ cells_NNS or_CC CHO_NP LRP-null_NP cells_NNS stably_RB transfected_VBN with_IN mLRP4_JJ tail_JJ truncation_NN mutants_NNS were_VBD seeded_VBN at_IN 1.5_CD x_NN 106_CD cells_NNS per_IN 60-mm_JJ dish_NN and_CC cultured_VBD overnight_RB before_IN experiments_NNS ._SENT Cells_NNS were_VBD incubated_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN proteasome_JJ inhibitors_NNS (_( 20_CD muM_NN MG132_NN or_CC lactacystin_NN )_) at_IN 37C_JJ as_RB indicated_VBN in_IN each_DT experiment_NN ._SENT Cell_NN monolayers_NNS were_VBD then_RB washed_VBN twice_RB in_IN prechilled_JJ PBSc_NP and_CC lysed_VBN with_IN 0.5_CD ml_NN of_IN lysis_NN buffer_NN ._SENT Equal_JJ quantities_NNS of_IN protein_NN were_VBD subjected_VBN to_TO SDS-PAGE_NP (_( 6_CD %_NN )_) under_IN reducing_VBG conditions_NNS ._SENT After_IN transfer_NN to_TO PVDF_NP membrane_NN ,_, successive_JJ incubations_NNS with_IN anti-HA_NN antibody_NN and_CC horseradish_NN peroxidase_NN --_: conjugated_JJ goat_NN anti-mouse_NN IgG_NP were_VBD carried_VBN out_RP for_IN 60_CD min_NN at_IN room_NN temperature_NN ._SENT The_DT immunoreactive_JJ proteins_NNS were_VBD then_RB detected_VBN using_VBG the_DT ECL_NN system_NN ._SENT Films_NNS showing_VBG immunoreactive_JJ bands_NNS were_VBD scanned_VBN by_IN Kodak_NP Digital_NP Science_NP DC120_NP Zoom_NP Digital_NP Camera_NP and_CC analyzed_VBD with_IN Kodak_NP Digital_NP Science1D_NP Image_NP Analysis_NP Software_NP (_( Eastman-Kodak_NP ,_, Rochester_NP ,_, NY_NP )_) ._SENT Flow_NP Cytometric_NP Analysis_NP of_IN Cell_NP Surface_NP LRP_NP Minireceptors_NP |_SYM CHO-mLRP4_JJ cells_NNS were_VBD seeded_VBN at_IN 1.2_CD x_NN 106_CD cells_NNS per_IN T25_NP flask_NN and_CC cultured_VBD overnight_RB before_IN experiments_NNS ._SENT Cells_NNS were_VBD washed_VBN in_IN serum-free_JJ medium_NN and_CC incubated_VBN with_IN or_CC without_IN proteasomal_JJ inhibitors_NNS (_( 20_CD muM_NN MG132_NN or_CC lactacystin_NN )_) for_IN varying_VBG lengths_NNS of_IN time_NN ._SENT Cells_NNS were_VBD then_RB detached_VBN by_IN incubation_NN with_IN nonenzymatic_JJ cell_NN dissociation_NN solution_NN (_( Sigma_NP )_) ._SENT Successive_JJ incubations_NNS with_IN affinity-purified_JJ anti-HA_NP IgG_NP (_( 25_CD mug/ml_NN )_) and_CC goat_NN anti-mouse_NN Ig-FITC_NP were_VBD carried_VBN out_RP at_IN 4C_JJ for_IN 45_CD min_NN each_DT ._SENT Background_NN fluorescence_NN intensity_NN was_VBD assessed_VBN in_IN the_DT absence_NN of_IN primary_JJ mAb_NN and_CC subtracted_VBN from_IN all_DT samples_NNS ._SENT Mean_JJ fluorescence_NN values_NNS were_VBD obtained_VBN in_IN at_IN least_JJS triplicate_NN on_IN a_DT FACScalibur_NP (_( BD_NP Biosciences-PharMingen_NP )_) ,_, and_CC data_NNS were_VBD analyzed_VBN with_IN Cell_NP Quest_NP software_NN ._SENT Kinetic_JJ Analysis_NN of_IN mLRP4_JJ Endocytosis_NN |_SYM Fifty_JJ micrograms_NNS of_IN RAP_NP were_VBD iodinated_VBN using_VBG the_DT Iodogen_NP method_NN as_RB described_VBD ._SENT Kinetic_JJ analysis_NN of_IN endocytosis_NN was_VBD performed_VBN essentially_RB as_RB described_VBN ._SENT Briefly_RB ,_, CHO-mLRP4_NP cells_NNS were_VBD plated_VBN in_IN 12-well_NP plates_NNS at_IN a_DT density_NN of_IN 2_CD x_SYM 105_CD cells/well_NN and_CC used_VBN after_IN overnight_JJ culture_NN ._SENT Cells_NNS were_VBD pretreated_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN MG132_NP (_( 20_CD muM_NN )_) for_IN either_DT 30_CD min_NN or_CC 2_CD h._JJ 125I-RAP_NN was_VBD added_VBN at_IN 5_CD nM_NN final_JJ concentrations_NNS in_IN cold_JJ ligand_NN binding_VBG buffer_NN (_( 0.5_CD ml/well_NN )_) ._SENT The_DT binding_NN of_IN 125I-RAP_NP was_VBD carried_VBN out_RP at_IN 4C_JJ for_IN 30_CD min_NN with_IN gentle_JJ rocking_VBG ._SENT Unbound_JJ ligand_NN was_VBD removed_VBN by_IN washing_VBG cell_NN monolayers_NNS three_CD times_NNS with_IN cold_JJ binding_JJ buffer_NN ._SENT Ice-cold_JJ stop/strip_NN solution_NN (_( 0.2_CD M_NP sodium_NN acetate/acetic_NN acid_NN ,_, pH_NN 2.6_CD ,_, 0.1_CD M_NP NaCl_NP )_) was_VBD added_VBN to_TO one_CD set_NN of_IN plates_NNS without_IN warming_VBG up_RP ._SENT The_DT remaining_VBG plates_NNS were_VBD then_RB placed_VBN in_IN a_DT 37C_JJ water_NN bath_NN ,_, and_CC 0.5_CD ml_NN of_IN ligand_NN binding_VBG buffer_NN with_IN or_CC without_IN MG132_NP and_CC prewarmed_VBN to_TO 37C_JJ was_VBD quickly_RB added_VBN to_TO the_DT cell_NN monolayers_NNS to_TO initiate_VB internalization_NN ._SENT After_IN each_DT time_NN point_NN ,_, the_DT plates_NNS were_VBD quickly_RB placed_VBN on_IN ice_NN and_CC the_DT ligand_NN binding_VBG buffer_NN was_VBD replaced_VBN with_IN cold_JJ stop/strip_NN solution_NN ._SENT Ligand_NN that_WDT remained_VBD on_IN the_DT cell_NN surface_NN was_VBD stripped_VBN by_IN incubation_NN of_IN cell_NN monolayers_NNS with_IN cold_JJ stop/strip_NN solution_NN for_IN a_DT total_NN of_IN 20_CD min_NN (_( 0.75_CD ml_NN for_IN 10_CD min_NN ,_, twice_JJ )_) and_CC counted_VBN ._SENT Cell_NN monolayers_NNS were_VBD then_RB solubilized_VBN with_IN low-SDS_NNS lysis_NN buffer_NN (_( 62.5_CD mM_NP Tris-HCl_NP ,_, pH_NN 6.8_CD ,_, 0.2%SDS_NNS ,_, 10_CD %_NN vol/vol_NN glycerol_NN ,_, and_CC 0.02_CD %_NN bromophenol_NN blue_NN )_) and_CC counted_VBN in_IN a_DT gamma_NN counter_NN ._SENT The_DT sum_NN of_IN ligand_NN that_WDT was_VBD internalized_VBN plus_CC that_IN remained_VBN on_IN the_DT cell_NN surface_NN after_IN each_DT assay_NN was_VBD used_VBN as_IN the_DT maximum_JJ potential_JJ internalization_NN ._SENT The_DT fraction_NN of_IN internalized_VBN ligand_NN after_IN each_DT time_NN point_NN was_VBD calculated_VBN and_CC plotted_VBN ._SENT Uptake_NN of_IN Cy3-labeled_NP Ligands_NP and_CC Confocal_NP Immunofluorescence_NP Microscopy_NP |_SYM Ts20-mLRP4_NN or_CC ts20-GHR_NN cells_NNS were_VBD grown_VBN on_IN glass_NN coverslips_NNS overnight_JJ before_IN experiments_NNS ._SENT Cells_NNS were_VBD then_RB incubated_VBN at_IN 30_CD ,_, 41.5_CD ,_, or_CC at_IN 30C_JJ with_IN either_DT DMSO_NP or_CC DMSO_NP containing_VBG 20_CD muM_NN MG132_NN for_IN 1_CD h._JJ Incubation_NN was_VBD continued_VBN for_IN 10_CD min_NN with_IN Cy3-RAP_NP (_( 20_CD nM_NN )_) or_CC 30_CD min_NN with_IN Cy3-GH_NP (_( 8_CD nM_NN )_) at_IN 30_CD or_CC 41.5C_JJ ._SENT After_IN medium_JJ aspiration_NN ,_, cells_NNS were_VBD washed_VBN once_RB with_IN PBS_NP and_CC once_RB with_IN fixative_JJ (_( 3_CD %_NN paraformaldehyde_NN in_IN 0.1_CD M_NP sodium_NN phosphate_NN ,_, pH_NN 7.2_CD )_) ,_, fixed_VBN for_IN 3_CD h_NN in_IN fixative_NN ,_, washed_VBN with_IN PBS_NP and_CC water_NN ,_, and_CC embedded_VBN in_IN Mowiol_NP ._SENT The_DT laser_NN scanning_VBG microscopy_NN was_VBD performed_VBN using_VBG a_DT TCS_JJ 4D_JJ system_NN and_CC 63x_JJ oil_NN immersion_NN lens_NN (_( Bensheim_NP ,_, Germany_NP )_) ._SENT Uptake_NN and_CC Degradation_NN of_IN Radiolabeled_NP Ligands_NP |_SYM Iodinated_JJ uPA-PAI-1_JJ complexes_NNS were_VBD added_VBN to_TO vehicle_NN or_CC drug-pretreated_JJ cells_NNS as_RB described_VBD above_IN ._SENT Radiolabeled_JJ ligand_NN with_IN or_CC without_IN excess_JJ unlabeled_JJ RAP_NN (_( 0.5_CD muM_NN )_) was_VBD incubated_VBN for_IN 4_CD h_NN at_IN 37C_JJ ._SENT The_DT overlying_VBG media_NNS were_VBD collected_VBN from_IN cells_NNS and_CC precipitated_VBD with_IN 20_CD %_NN trichloroacetic_JJ acid_NN (_( TCA_NP )_) ._SENT TCA_NP soluble_JJ counts_NNS ,_, after_IN subtraction_NN of_IN TCA-soluble_JJ counts_NNS in_IN well_RB contained_VBN no_DT cells_NNS ,_, were_VBD used_VBN to_TO represent_VB cell-mediated_JJ degradation_NN of_IN radiolabeled_JJ ligand_NN ._SENT Unbound_JJ ligand_NN was_VBD removed_VBN by_IN washing_VBG cell_NN monolayers_NNS three_CD times_NNS with_IN cold_JJ binding_JJ buffer_NN ._SENT Ligand_NN that_WDT remained_VBD on_IN the_DT cell_NN surface_NN was_VBD stripped_VBN by_IN incubation_NN of_IN cell_NN monolayers_NNS with_IN cold_JJ stop/strip_NN solution_NN for_IN a_DT total_NN of_IN 20_CD min_NN and_CC counted_VBN ._SENT Cell_NN monolayers_NNS were_VBD then_RB washed_VBN twice_RB in_IN PBSc_NP and_CC lysed_VBN in_IN low-SDS_NNS buffer_NN to_TO quantitate_VB cell-associated_JJ ligand_NN ._SENT Immunoelectron_NP Microscopy_NP |_SYM CHO-mLRP4_JJ cells_NNS were_VBD incubated_VBN in_IN the_DT absence_NN or_CC presence_NN of_IN 20_CD muM_NN MG132_NN for_IN 2_CD h_NN and_CC thereafter_RB fixed_VBN in_IN a_DT mixture_NN of_IN 2_CD %_NN paraformaldehyde_NN and_CC 0.5_CD %_NN glutaraldehyde_NN in_IN 0.1_CD M_NP phosphate_NN buffer_NN ,_, pH_NN 7.4_CD ,_, for_IN 1_CD h_NN and_CC then_RB stored_VBN in_IN the_DT same_JJ buffer_NN containing_VBG 1_CD %_NN paraformaldehyde_NN until_IN use_NN ._SENT Cryosections_NNS of_IN 50_CD --_: 100_CD nm_NN were_VBD picked_VBN up_RP from_IN the_DT diamond_NN knife_NN in_IN a_DT sucrose/methylcellulose_NN mixture_NN and_CC sequentially_RB incubated_VBN with_IN mouse_NN monoclonal_NN HA_NP antibody_NN ,_, polyclonal_JJ rabbit_NN anti-mouse_NN IgG_NP (_( Dako_NP ,_, Copenhagen_NP ,_, Denmark_NP )_) ,_, and_CC 10-nm_NP protein_NN A_NP --_: conjugated_JJ gold_JJ particles_NNS (_( for_IN technical_JJ details_NNS see_VBP )_) ._SENT mLRP4_NN labeling_VBG at_IN the_DT cell_NN surface_NN was_VBD quantitatively_RB evaluated_VBN in_IN a_DT total_NN of_IN 50_CD electron_NN micrographs_NNS at_IN x15,000_NN taken_VBN randomly_RB from_IN sections_NNS of_IN two_CD blocks_NNS with_IN control_NN and_CC two_CD blocks_NNS of_IN MG132-treated_JJ cells_NNS ._SENT Totals_NNS of_IN gold_NN particles_NNS and_CC measured_VBN plasma_NN membrane_NN lengths_NNS in_IN control_NN cells_NNS and_CC MG132_JJ cells_NNS were_VBD 680/969_CD and_CC 1733/949_CD mum_NN ,_, respectively_RB ._SENT mLRP4_JJ labeling_VBG densities_NNS represented_VBN by_IN the_DT ratios_NNS of_IN gold_JJ particles_NNS over_IN plasma_NN membrane_NN length_NN were_VBD 0.76_CD +-_NN 1.12_CD and_CC 1.78_CD +-_NN 2.08_CD (_( means_NN +-_NN SD_NN )_) in_IN control_NN and_CC MG132_JJ cells_NNS ,_, respectively_RB ._SENT Inhibition_NN of_IN Proteasome_NP Activity_NP Increases_VBZ the_DT Half-Life_NP and_CC the_DT Steady_NP State_NP Levels_NP of_IN LRP_NP |_SYM To_TO determine_VB whether_IN proteasomal_JJ inhibitors_NNS influence_VBP the_DT cellular_JJ turnover_NN of_IN LRP_NP ,_, we_PP analyzed_VBD the_DT half-life_NN of_IN LRP_NP in_IN the_DT absence_NN or_CC presence_NN of_IN the_DT proteasome_JJ inhibitor_NN MG132_NP in_IN HepG2_NP cells_NNS ._SENT These_DT cells_NNS were_VBD metabolically_RB pulse_NN labeled_VBN with_IN [_SYM 35S]cysteine_JJ for_IN 30_CD min_NN and_CC chased_VBD for_IN 0.5_CD ,_, 1_CD ,_, 2_CD ,_, 4_CD ,_, or_CC 8_CD h_NN ,_, in_IN the_DT absence_NN or_CC presence_NN of_IN MG132_NP (_( 20_CD muM_NN )_) ._SENT After_IN each_DT chase_JJ time_NN ,_, cell_NN lysates_NNS were_VBD quantitatively_RB immunoprecipitated_VBN with_IN anti-LRP_NP antibody_NN and_CC analyzed_VBD by_IN SDS-PAGE_NP under_IN reducing_VBG conditions_NNS (_( Figure_NP A_NP )_) ._SENT When_WRB the_DT band_NN intensities_NNS were_VBD quantitated_VBN with_IN a_DT phosphorimager_NN ,_, we_PP found_VBD that_IN the_DT half-life_NN of_IN LRP_NP is_VBZ prolonged_JJ from_IN similar3_JJ h_NN in_IN the_DT absence_NN of_IN MG132_NP to_TO >8_JJ h_NN in_IN the_DT presence_NN of_IN MG132_NP (_( Figure_NP B_NP )_) ._SENT Similar_JJ results_NNS were_VBD obtained_VBN when_WRB lactacystein_NP ,_, was_VBD used_VBN as_IN the_DT proteasomal_JJ inhibitor_NN ._SENT Figure_NP 1_CD |_SYM The_DT proteasomal_JJ inhibitor_NN MG132_NP prolongs_VBZ the_DT cellular_JJ half-life_NN of_IN LRP_NP ._SENT The_DT proteasomal_JJ inhibitor_NN MG132_NP prolongs_VBZ the_DT cellular_JJ half-life_NN of_IN LRP_NP ._SENT (_( A_NP )_) HepG2_NP cells_NNS were_VBD metabolically_RB labeled_VBN with_IN [_SYM 35S]cysteine_JJ for_IN 30_CD min_NN and_CC chased_VBD for_IN the_DT indicated_JJ times_NNS ,_, in_IN the_DT absence_NN or_CC presence_NN of_IN MG132_NP (_( 20_CD muM_NN )_) ._SENT After_IN each_DT chase_NN ,_, cell_NN lysates_NNS were_VBD immunoprecipitated_VBN with_IN anti-LRP_NP antibody_NN and_CC analyzed_VBD with_IN SDS_NP gels_NNS (_( 5_CD %_NN )_) under_IN reducing_VBG conditions_NNS ._SENT The_DT 200-kDa_JJ molecular_JJ size_NN marker_NN is_VBZ indicated_VBN ._SENT (_( B_LS )_) The_DT band_NN intensities_NNS in_IN A_DT were_VBD quantitated_VBN and_CC plotted_VBN against_IN chase_JJ times_NNS ._SENT Many_JJ of_IN our_PP$ recent_JJ studies_NNS on_IN LRP_NP endocytosis_NN and_CC trafficking_NN have_VBP been_VBN carried_VBN out_RP mostly_RB using_VBG a_DT minireceptor_NN form_NN of_IN LRP_NP ,_, which_WDT includes_VBZ the_DT fourth_JJ ligand-binding_NN domain_NN and_CC the_DT entire_JJ carboxyl-terminus_NN of_IN the_DT receptor_NN ._SENT This_DT receptor_NN ,_, referred_VBD to_TO as_IN mLRP4_NN ,_, exhibits_VBZ similar_JJ biogenesis_NN and_CC trafficking_NN with_IN the_DT endogenous_JJ full-length_JJ receptor_NN ,_, including_VBG the_DT furin_NN cleavage_NN to_TO generate_VB the_DT two_CD subunits_NN ._SENT One_CD advantage_NN of_IN this_DT minireceptor_NN is_VBZ the_DT ability_NN to_TO readily_RB distinguish_VB the_DT mature_JJ form_NN from_IN the_DT precursor_NN form_NN of_IN the_DT protein_NN ,_, which_WDT is_VBZ extremely_RB difficult_JJ for_IN the_DT endogenous_JJ full-length_JJ LRP_NP because_IN of_IN its_PP$ large_JJ size_NN ._SENT Additionally_RB ,_, mLRP4_NN is_VBZ tagged_VBN with_IN an_DT HA_NP epitope_NN near_IN its_PP$ amino-terminus_NN ,_, which_WDT facilitates_VBZ various_JJ immunodetection_NN strategies_NNS including_VBG immunoelectron_NN microscopy_NN (_( see_VB below_IN )_) ._SENT To_TO examine_VB whether_IN the_DT cellular_JJ turnover_NN of_IN mLRP4_NN is_VBZ also_RB regulated_VBN by_IN the_DT proteasome_NN ,_, we_PP performed_VBD metabolic_JJ pulse-chase_NN labeling_VBG with_IN mLRP4_NN stably_RB expressed_VBD in_IN CHO_NP LRP-null_NP cells_NNS (_( ;_: stable_JJ cell_NN line_NN is_VBZ termed_VBN CHO-mLRP4_NN )_) ._SENT Seen_VBN in_IN Figure_NN are_VBP results_NNS from_IN a_DT representative_JJ experiment_NN ._SENT As_IN seen_VBN in_IN the_DT figure_NN ,_, the_DT presence_NN of_IN MG132_NP significantly_RB increased_VBD the_DT half-life_NN of_IN the_DT mature_JJ forms_NNS of_IN mLRP_NP while_IN exhibiting_VBG little_JJ effect_NN on_IN the_DT precursor_NN form_NN ;_: the_DT half-life_NN of_IN mLRP4_NN was_VBD increased_VBN from_IN similar2.5_NN to_TO similar5.5_JJ h._NN To_TO exclude_VB the_DT possibility_NN that_IN the_DT effect_NN of_IN proteasome_JJ inhibitor_NN on_IN the_DT half-life_NN mLRP4_NN was_VBD due_JJ to_TO the_DT different_JJ cell_NN lines_NNS used_VBN in_IN our_PP$ studies_NNS ,_, we_PP also_RB performed_VBD pulse_NN chase_NN experiments_NNS to_TO examine_VB mLRP4_JJ half-life_NN in_IN mLRP4-transiently_RB transfected_JJ HepG2_NP cells_NNS ._SENT We_PP found_VBD that_IN MG132_NP increased_VBD the_DT half-life_NN of_IN mLRP4_NN in_IN HepG2_JJ cells_NNS from_IN similar4.2_NN to_TO 8.1_CD h._NN These_DT results_NNS demonstrate_VBP that_IN the_DT proteasome_JJ inhibitor_NN MG132_NP increases_VBZ the_DT half-life_NN of_IN mLRP4_NN in_IN both_DT CHO_NP LRP-null_NP cells_NNS and_CC HepG2_JJ cells_NNS ._SENT Figure_NP 2_CD |_SYM The_DT proteasomal_JJ inhibitor_NN MG132_NP increases_VBZ the_DT half-life_NN of_IN a_DT LRP_NP minireceptor_NN ,_, mLRP4_NN ._SENT The_DT proteasomal_JJ inhibitor_NN MG132_NP increases_VBZ the_DT half-life_NN of_IN a_DT LRP_NP minireceptor_NN ,_, mLRP4_NN ._SENT CHO-mLRP4_NP cells_NNS were_VBD metabolically_RB labeled_VBN with_IN [_SYM 35S]cysteine_JJ for_IN 30_CD min_NN and_CC chased_VBD for_IN the_DT indicated_JJ times_NNS ,_, in_IN the_DT absence_NN or_CC presence_NN of_IN MG132_NP (_( 20_CD muM_NN )_) ._SENT After_IN each_DT chase_NN ,_, cell_NN lysates_NNS were_VBD immunoprecipitated_VBN with_IN anti-HA_NN antibody_NN and_CC analyzed_VBD with_IN SDS_NP gels_NNS (_( 6_CD %_NN )_) under_IN reducing_VBG conditions_NNS ._SENT The_DT molecular_JJ size_NN markers_NNS in_IN this_DT and_CC subsequent_JJ figures_NNS are_VBP given_VBN in_IN kilodaltons_NNS on_IN the_DT left_NN ._SENT The_DT positions_NNS of_IN the_DT precursor_NN and_CC the_DT mature_JJ forms_NNS of_IN mLRP4_NN are_VBP marked_VBN ._SENT (_( B_LS )_) The_DT band_NN intensities_NNS in_IN A_DT (_( includes_VBZ the_DT precursor_NN and_CC the_DT mature_JJ forms_NNS )_) were_VBD quantitated_VBN and_CC plotted_VBN against_IN chase_JJ time_NN ._SENT To_TO examine_VB whether_IN an_DT increase_NN of_IN mLRP4_JJ half-life_NN results_NNS in_IN an_DT increase_NN in_IN the_DT steady_JJ state_NN level_NN of_IN mLRP4_NN ,_, we_PP treated_VBD CHO-mLRP4_NP cells_NNS for_IN various_JJ periods_NNS of_IN time_NN and_CC analyzed_VBD the_DT total_JJ cellular_JJ mLRP4_NN via_IN Western_NP blotting_VBG with_IN anti-HA_NN antibody_NN ._SENT Only_RB the_DT precursor_NN form_NN and_CC the_DT ligand-binding_JJ subunit_NN of_IN the_DT mature_JJ form_NN are_VBP shown_VBN in_IN the_DT blot_NN because_IN these_DT forms_NNS ,_, but_CC not_RB the_DT 85-kDa_JJ subunit_NN mature_JJ form_NN ,_, contain_VBP the_DT HA_NP epitope_NN ._SENT As_IN seen_VBN in_IN Figure_NP A_NP ,_, a_DT significant_JJ increase_NN of_IN the_DT mature_JJ form_NN ,_, which_WDT is_VBZ present_JJ at_IN the_DT cell_NN surface_NN and_CC later_JJR compartments_NNS of_IN the_DT endocytic_JJ pathway_NN ,_, is_VBZ seen_VBN in_IN the_DT presence_NN of_IN MG132_NP ._SENT An_DT average_NN of_IN similar2.5-fold_NN increase_NN of_IN mature_JJ mLRP4_NN was_VBD consistently_RB observed_VBN using_VBG this_DT method_NN ._SENT The_DT increase_NN in_IN steady_JJ state_NN level_NN of_IN mLRP4_NN was_VBD also_RB seen_VBN upon_IN incubation_NN with_IN lactacystin_NN but_CC not_RB with_IN the_DT vehicle_NN DMSO_NP alone_RB (_( Figure_NP B_NP )_) ._SENT These_DT results_NNS suggest_VBP that_IN the_DT cellular_JJ turnover_NN of_IN LRP_NP is_VBZ mediated_VBN via_IN or_CC regulated_VBN by_IN proteasomal_JJ activity_NN ._SENT Figure_NP 3_CD |_SYM Treatment_NP of_IN CHO-mLRP4_NP cells_NNS with_IN proteasomal_JJ inhibitors_NNS increases_VBZ the_DT steady_JJ state_NN levels_NNS of_IN mLRP4_NN ._SENT Treatment_NN of_IN CHO-mLRP4_NP cells_NNS with_IN proteasomal_JJ inhibitors_NNS increases_VBZ the_DT steady_JJ state_NN levels_NNS of_IN mLRP4_NN ._SENT (_( A_NP )_) CHO-mLRP4_NP cells_NNS were_VBD treated_VBN with_IN either_DT vehicle_NN DMSO_NP or_CC DMSO_NP containing_VBG MG132_NP (_( 20_CD muM_NN )_) for_IN various_JJ periods_NNS of_IN time_NN ._SENT Equal_JJ quantities_NNS of_IN cell_NN lysates_NNS were_VBD separated_VBN via_IN SDS_NP gel_NN (_( 6_CD %_NN )_) and_CC blotted_VBN with_IN anti-HA_NN antibody_NN ._SENT Only_RB the_DT precursor_NN form_NN and_CC the_DT ligand-binding_JJ subunit_NN of_IN the_DT mature_JJ form_NN are_VBP detected_VBN in_IN the_DT blot_NN because_IN these_DT forms_NNS ,_, but_CC not_RB the_DT 85-kDa_JJ subunit_NN mature_JJ form_NN ,_, contain_VBP the_DT HA_NP epitope_NN ._SENT Note_VB the_DT increase_NN of_IN the_DT mature_JJ form_NN ,_, but_CC not_RB the_DT precursor_NN form_NN of_IN mLRP4_NN after_IN MG132_JJ treatment_NN ._SENT (_( B_LS )_) The_DT effects_NNS of_IN proteasomal_JJ inhibition_NN on_IN steady_JJ state_NN levels_NNS of_IN mLRP4_NN were_VBD also_RB seen_VBN with_IN lactacystin_NN ,_, but_CC not_RB with_IN vehicle_NN DMSO_NP alone_RB ._SENT Treatment_NN of_IN Cells_NP with_IN Proteasomal_NP Inhibitors_NP also_RB Increased_VBD Cell_NP Surface_NP mLRP4_NP |_SYM To_TO analyze_VB whether_IN upon_IN treatment_NN of_IN cells_NNS with_IN proteasome_JJ inhibitors_NNS there_EX was_VBD also_RB a_DT change_NN of_IN cell_NN surface_NN mLRP4_NN ,_, we_PP performed_VBD FACS_NP analysis_NN using_VBG the_DT anti-HA_NN antibody_NN ._SENT As_IN seen_VBN in_IN Figure_NP A_NP ,_, we_PP consistently_RB observed_VBD an_DT approximately_RB threefold_JJ increase_NN (_( average_JJ of_IN 5_CD experiments_NNS )_) of_IN cell_NN surface_NN mLRP4_NN after_IN a_DT 2-h_JJ treatment_NN of_IN CHO-mLRP4_NP cells_NNS with_IN MG132_NP ._SENT To_TO examine_VB the_DT kinetics_NN of_IN the_DT cell_NN surface_NN increase_NN of_IN mLRP4_NN ,_, we_PP treated_VBD CHO-mLRP4_NP cells_NNS with_IN MG132_NP for_IN increasing_VBG periods_NNS of_IN time_NN and_CC measured_JJ cell_NN surface_NN mLRP4_NN via_IN FACS_NP analyses_NNS ._SENT Shown_VBN in_IN Figure_NP B_NP are_VBP results_NNS from_IN a_DT representative_JJ experiment_NN ._SENT As_IN seen_VBN in_IN the_DT figure_NN ,_, there_EX is_VBZ a_DT gradual_JJ increase_NN of_IN cell_NN surface_NN mLRP4_NN upon_IN MG132_JJ treatment_NN ,_, suggesting_VBG that_IN the_DT cell_NN surface_NN increase_NN of_IN mLRP4_NN is_VBZ cumulative_JJ ._SENT A_DT similar_JJ increase_NN in_IN cell_NN surface_NN mLRP4_NN was_VBD also_RB observed_VBN ,_, at_IN the_DT selected_VBN time_NN points_NNS ,_, with_IN lactacystin_NN ,_, but_CC not_RB with_IN vehicle_NN DMSO_NP alone_RB (_( Figure_NP B_NP )_) ._SENT These_DT results_NNS suggest_VBP that_IN proteasomal_JJ inhibitors_NNS likely_RB block_VB LRP_NP trafficking_NN at_IN an_DT endosomal_JJ compartment_NN (_( e.g._FW ,_, sorting_VBG endosome_NN )_) from_IN which_WDT the_DT receptor_NN is_VBZ still_RB able_JJ to_TO recycle_VB to_TO the_DT cell_NN surface_NN ._SENT Figure_NP 4_CD |_SYM Proteasomal_JJ inhibitors_NNS increase_NN cell_NN surface_NN mLRP4_NN ._SENT Proteasomal_JJ inhibitors_NNS increase_NN cell_NN surface_NN mLRP4_NN ._SENT (_( A_NP )_) CHO-mLRP4_NP cells_NNS were_VBD treated_VBN with_IN DMSO_NP or_CC DMSO_NP containing_VBG MG132_NP (_( 20_CD muM_NN )_) for_IN 2_CD h._NP Cells_NP were_VBD then_RB dissociated_VBN and_CC immunostained_VBN with_IN anti-HA_NN antibody_NN ._SENT Cell_NN surface_NN mLRP4_NN was_VBD detected_VBN with_IN goat_NN anti-mouse_NN Ig-FITC_NP and_CC FACS_NP analysis_NN ._SENT Background_NN fluorescence_NN intensity_NN was_VBD assessed_VBN in_IN the_DT absence_NN of_IN primary_JJ antibody_NN and_CC subtracted_VBN from_IN each_DT assay_NN ._SENT The_DT mean_JJ values_NNS from_IN representative_JJ triplicate_JJ determinations_NNS were_VBD averaged_VBN with_IN the_DT SE_JJ value_NN given_VBN as_IN error_NN bars_NNS ._SENT (_( B_NP )_) Kinetic_NP analyses_NNS of_IN cell_NN surface_NN mLRP4_NN after_IN treatment_NN with_IN proteasomal_JJ inhibitors_NNS ._SENT CHO-mLRP4_NP cells_NNS were_VBD treated_VBN with_IN MG132_NP (_( 20_CD muM_NN )_) for_IN various_JJ periods_NNS of_IN time_NN as_RB indicated_VBD ._SENT Treatment_NN with_IN the_DT alternative_JJ proteasome_JJ inhibitor_NN lactacystin_NN (_( 20_CD muM_NN )_) or_CC vehicle_NN DMSO_NP alone_RB were_VBD also_RB performed_VBN at_IN selected_JJ time_NN points_NNS ._SENT Cell_NN surface_NN mLRP4_NN was_VBD determined_VBN via_IN FACS_NP analysis_NN as_RB indicated_VBD above_IN ._SENT Shown_VBN in_IN the_DT figure_NN are_VBP results_NNS of_IN a_DT representative_JJ experiment_NN ._SENT Note_VB the_DT gradual_JJ increase_NN of_IN cell_NN surface_NN mLRP4_NN upon_IN treatment_NN with_IN proteasomal_JJ inhibitors_NNS ,_, but_CC not_RB DMSO_NP ._SENT Proteasomal_NP Inhibitors_NP Slow_NP ,_, but_CC Do_VBP Not_RB Block_NN the_DT Initial_JJ Endocytosis_NN of_IN mLRP4_NP |_SYM Recent_JJ studies_NNS have_VBP shown_VBN that_IN the_DT proteasome_NN regulates_VBZ not_RB only_RB the_DT degradation_NN but_CC also_RB the_DT initial_JJ endocytosis_NN of_IN several_JJ cell_NN surface_NN receptors_NNS including_VBG the_DT GHR_NN ._SENT To_TO determine_VB whether_IN the_DT endocytosis_NN of_IN mLRP4_NN is_VBZ regulated_VBN by_IN proteasomal_JJ activity_NN ,_, we_PP quantitated_VBD the_DT initial_JJ endocytosis_NN rate_NN of_IN mLRP4_NN after_IN pretreatment_NN of_IN cells_NNS with_IN MG132_NP for_IN either_DT 30_CD min_NN (_( Figure_NP A_NP )_) or_CC 2_CD h_NN (_( Figure_NP B_NP )_) ._SENT As_IN seen_VBN in_IN Figure_NP A_NP ,_, there_EX was_VBD no_DT significant_JJ change_NN of_IN mLRP4_JJ endocytosis_NN rate_NN when_WRB cells_NNS were_VBD pretreated_VBN with_IN MG132_NP for_IN only_RB 30_CD min_NN ._SENT However_RB ,_, a_DT significant_JJ (_( similar40_JJ %_NN )_) decrease_NN in_IN mLRP4_JJ endocytosis_NN rate_NN was_VBD seen_VBN when_WRB cells_NNS were_VBD pretreated_VBN for_IN 2_CD h_NN with_IN MG132_NP (_( Figure_NP B_NP )_) ._SENT It_PP is_VBZ important_JJ to_TO point_VB out_RP that_IN although_IN the_DT initial_JJ (_( <=30_s) 120_CD s._NP Figure_NP 5_CD |_SYM The_DT initial_JJ endocytosis_NN of_IN mLRP4_NN is_VBZ slowed_VBN ,_, but_CC not_RB blocked_VBN by_IN proteasomal_JJ inhibitors_NNS ._SENT The_DT initial_JJ endocytosis_NN of_IN mLRP4_NN is_VBZ slowed_VBN ,_, but_CC not_RB blocked_VBN by_IN proteasomal_JJ inhibitors_NNS ._SENT CHO-mLRP4_NP cells_NNS were_VBD pretreated_VBN with_IN DMSO_NP or_CC DMSO_NP containing_VBG MG132_NP (_( 20_CD muM_NN )_) for_IN either_DT 30_CD min_NN (_( A_NP )_) or_CC 2_CD h_NN (_( B_NP )_) ._SENT The_DT initial_JJ endocytosis_NN rates_NNS of_IN mLRP4_NN were_VBD measured_VBN using_VBG 125I-RAP_JJ as_IN described_VBN in_IN MATERIALS_NP AND_CC METHODS_NP ._SENT Data_NNS represent_VBP triplicate_JJ determination_NN with_IN SE_JJ values_NNS given_VBN as_IN error_NN bars_NNS ._SENT To_TO determine_VB whether_IN a_DT functional_JJ ubiquitin_NN system_NN is_VBZ required_VBN for_IN LRP-mediated_JJ endocytosis_NN ,_, we_PP compared_VBD the_DT endocytosis_NN of_IN ligands_NNS for_IN mLRP4_NN (_( RAP_NP )_) and_CC GHR_NP (_( GH_NP )_) in_IN ts20_NN cells_NNS stably_RB expressing_VBG mLRP4_NN (_( ts20-mLRP4_NN )_) or_CC GHR_NP (_( ts20-GHR_NN )_) ._SENT The_DT ts20_NN cells_NNS express_VBP a_DT thermolabile_JJ ,_, ubiquitin-activating_JJ enzyme_NN ,_, E1_NP ._SENT At_IN the_DT permissive_JJ temperature_NN (_( 30C_JJ )_) ,_, both_CC Cy3-RAP_NP (_( Figure_NP A_NP )_) and_CC Cy3-GH_NP (_( Figure_NP B_NP )_) were_VBD endocytosed_VBN ._SENT However_RB ,_, at_IN the_DT nonpermissive_JJ temperature_NN (_( 41.5C_JJ )_) ,_, wherein_RB the_DT ubiquitin_NN activating_VBG enzyme_NN is_VBZ inactivated_VBN ,_, Cy3-RAP_NP (_( Figure_NP C_NP )_) ,_, but_CC not_RB Cy3-GH_NP (_( Figure_NP D_NP )_) ,_, were_VBD internalized_VBN ._SENT This_DT indicates_VBZ that_IN the_DT initial_JJ endocytosis_NN of_IN GHR_NP ,_, but_CC not_RB mLRP4_JJ ,_, requires_VBZ a_DT functional_JJ ubiquitin-activating/conjugating_NN system_NN ._SENT Using_VBG similar_JJ assays_NNS at_IN the_DT permissive_JJ temperature_NN ,_, we_PP also_RB found_VBD that_IN the_DT proteasomal_JJ inhibitor_NN ,_, MG132_NP ,_, inhibits_VBZ the_DT endocytosis_NN of_IN GH_NP (_( Figure_NP F_NP )_) ,_, but_CC not_RB RAP_NP (_( Figure_NP E_NP )_) ,_, consistent_JJ with_IN our_PP$ previous_JJ observation_NN that_IN the_DT initial_JJ endocytosis_NN of_IN the_DT GHR_NN ,_, but_CC not_RB mLRP4_JJ ,_, requires_VBZ proteasomal_JJ activity_NN (_( ;_: also_RB see_VBP Figure_NN )_) ._SENT We_PP confirmed_VBD the_DT clathrin-dependence_NN of_IN mLRP4_NN and_CC GHR_NN endocytosis_NN because_IN potassium-depletion_NN inhibited_VBN Cy3-RAP_NP and_CC Cy3-GH_NP endocytosis_NN ._SENT Figure_NP 6_CD |_SYM A_DT functional_JJ ubiquitin_NN conjugation_NN system_NN is_VBZ not_RB required_VBN for_IN mLRP4-mediated_JJ endocytosis_NN ._SENT A_DT functional_JJ ubiquitin_NN conjugation_NN system_NN is_VBZ not_RB required_VBN for_IN mLRP4-mediated_JJ endocytosis_NN ._SENT CHO-ts20-mLRP4_NP or_CC CHO-ts20-GHR_NP cells_NNS were_VBD incubated_VBN with_IN Cy3-RAP_NP (_( 20_CD nM_NN )_) for_IN 10_CD min_NP or_CC Cy3-GH_NP for_IN 30_CD min_NN ,_, respectively_RB ,_, under_IN the_DT conditions_NNS indicated_VBD ._SENT Cells_NNS were_VBD washed_VBN ,_, fixed_VBN ,_, and_CC examined_VBD with_IN a_DT confocal_JJ microscope_NN ._SENT At_IN the_DT permissive_JJ temperature_NN (_( 30C_JJ )_) ,_, endocytosis_NN of_IN both_DT Cy3-RAP_NP (_( A_NP )_) and_CC Cy3-GH_NP (_( B_NP )_) is_VBZ observed_VBN by_IN the_DT appearance_NN of_IN punctuate_VB fluorescence_NN representing_VBG ligand_NN distribution_NN in_IN endocytic_JJ compartments_NNS ._SENT The_DT endocytosis_NN of_IN Cy3-GH_NP ,_, but_CC not_RB Cy3-RAP_NP ,_, was_VBD inhibited_VBN at_IN the_DT nonpermissive_JJ temperature_NN (_( 41.5C_JJ )_) ,_, and_CC in_IN the_DT presence_NN of_IN the_DT proteasomal_JJ inhibitor_NN MG132_NP (_( C-F_NP )_) ._SENT Our_PP$ previous_JJ studies_NNS have_VBP shown_VBN that_IN mLRP4_NN is_VBZ capable_JJ of_IN binding_VBG and_CC endocytosing_VBG several_JJ LRP_NP ligands_NNS ,_, including_VBG uPA-PAI-1_JJ complexes_NNS ._SENT To_TO examine_VB the_DT fate_NN of_IN mLRP4_JJ ligands_NNS in_IN the_DT absence_NN or_CC presence_NN of_IN proteasomal_JJ inhibitors_NNS ,_, we_PP performed_VBD ligand_NN uptake_NN and_CC degradation_NN assays_NNS using_VBG CHO-mLRP4_NP cells_NNS ._SENT In_IN this_DT experiment_NN ,_, 125I-uPA-PAI-1_JJ was_VBD incubated_VBN with_IN CHO-mLRP4_NP cells_NNS at_IN 37C_JJ for_IN 4_CD h._JJ Cell-mediated_JJ degradation_NN and_CC intracellular_JJ and_CC cell_NN surface_NN bound_VBN ligands_NNS were_VBD determined_VBN at_IN the_DT end_NN of_IN assay_NN ._SENT As_IN seen_VBN in_IN Figure_NP A_NP ,_, MG132_NP significantly_RB inhibited_VBD cellular_JJ degradation_NN of_IN 125I-uPA-PAI-1_JJ ._SENT A_DT corresponding_JJ increase_NN of_IN intracellular_JJ 125I-uPA-PAI-1_JJ was_VBD seen_VBN (_( Figure_NP B_NP )_) ,_, suggesting_VBG that_IN the_DT block_NN in_IN 125I-uPA-PAI-1_JJ degradation_NN likely_RB involves_VBZ inhibition_NN of_IN ligand_NN delivery_NN to_TO the_DT lysosomal_JJ compartment_NN ._SENT A_DT small_JJ increase_NN in_IN cell_NN surface_NN 125I-uPA-PAI-1_JJ was_VBD also_RB observed_JJ (_( Figure_NP C_NP )_) ,_, consistent_JJ with_IN the_DT fact_NN that_IN MG132_NP slows_VBZ mLRP4-mediated_JJ endocytosis_NN (_( see_VB Figure_NN )_) ._SENT Taken_VBN together_RB ,_, these_DT results_NNS indicate_VBP that_IN proteasomal_JJ activity_NN is_VBZ required_VBN for_IN intracellular_JJ trafficking_NN of_IN mLRP4_NN and_CC its_PP$ ligand_NN to_TO the_DT degradation_NN pathway_NN ._SENT Figure_NP 7_CD |_SYM Treatment_NP of_IN CHO-mLRP4_NP cells_NNS with_IN proteasomal_JJ inhibitors_NNS results_NNS in_IN intracellular_JJ accumulation_NN and_CC inhibition_NN of_IN degradation_NN of_IN mLRP4_JJ ligand_NN ._SENT Treatment_NN of_IN CHO-mLRP4_NP cells_NNS with_IN proteasomal_JJ inhibitors_NNS results_NNS in_IN intracellular_JJ accumulation_NN and_CC inhibition_NN of_IN degradation_NN of_IN mLRP4_JJ ligand_NN ._SENT 125I-uPA-PAI-1_JJ (_( 2_CD nM_NN )_) was_VBD incubated_VBN with_IN CHO-mLRP4_NP cells_NNS at_IN 37C_JJ for_IN 4_CD h._JJ Cell-mediated_JJ degradation_NN and_CC intracellular_JJ and_CC cell_NN surface_NN bound_VBN ligands_NNS were_VBD determined_VBN as_IN described_VBN in_IN MATERIALS_NP AND_CC METHODS_NP ._SENT Data_NNS represent_VBP triplicate_JJ determinations_NNS with_IN SE_JJ values_NNS given_VBN as_IN error_NN bars_NNS ._SENT Trafficking_NN of_IN mLRP4_NN to_TO the_DT Multivesicular_NP Bodies_NP Is_VBZ Blocked_JJ on_IN Proteasome_NP Inhibition_NP |_SYM To_TO examine_VB morphologically_RB the_DT effects_NNS of_IN proteasome_JJ inhibitors_NNS on_IN LRP_NP endocytic_JJ trafficking_NN ,_, we_PP performed_VBD immunogold_NN EM_NNS labeling_VBG of_IN mLRP4_NN in_IN MG132-treated_JJ and_CC control_NN cells_NNS ._SENT Differences_NNS in_IN mLRP4_NN labeling_VBG between_IN control_NN and_CC MG132_JJ cells_NNS mainly_RB concerned_VBN the_DT plasma_NN membrane_NN and_CC late_JJ endocytic_JJ compartments_NNS ._SENT First_RB ,_, in_IN control_NN cells_NNS most_RBS of_IN the_DT surface_NN mLRP4_NN was_VBD localized_VBN to_TO clathrin-coated_JJ pits_NNS (_( Figure_NP A_NP )_) ,_, similar_JJ to_TO what_WP we_PP have_VBP observed_VBN previously_RB for_IN the_DT endogenous_JJ LRP_NP ._SENT However_RB ,_, in_IN MG132-treated_JJ cells_NNS ,_, mLRP4_NN is_VBZ observed_VBN in_IN both_DT clathrin-coated_JJ pits_NNS ,_, and_CC outside_IN the_DT pits_NNS (_( Figure_NP ,_, B_NP and_CC E_NP )_) ._SENT A_DT quantitative_JJ evaluation_NN of_IN the_DT labeling_VBG at_IN the_DT plasma_NN membrane_NN revealed_VBD a_DT statistically_RB significant_JJ 2.5-fold_NN greater_JJR labeling_VBG density_NN of_IN mLRP4_NN in_IN MG132_JJ cells_NNS than_IN in_IN control_NN cells_NNS (_( see_VB MATERIALS_NNS AND_CC METHODS_NNS for_IN quantitation_NN results_NNS )_) ._SENT Second_RB ,_, mLRP4_NN in_IN control_NN cells_NNS was_VBD found_VBN throughout_IN the_DT endocytic_JJ pathway_NN ,_, i.e._FW ,_, primary_JJ endocytic_JJ vesicles_NNS ,_, multivesicular_JJ bodies_NNS (_( MVBs_NP ;_: Figure_NP ,_, C_NP and_CC D_NP )_) ,_, and_CC lysosomes_NNS ._SENT Within_IN the_DT MVBs_NP ,_, mLRP4_NN labels_NNS were_VBD associated_VBN with_IN both_CC the_DT limiting_VBG membrane_NN and_CC the_DT internal_JJ vesicles_NNS ,_, thought_VBD to_TO be_VB destined_VBN for_IN degradation_NN ._SENT The_DT limiting_VBG membrane_NN showed_VBD triple-layered_JJ ,_, clathrin-coated_JJ lattices_NNS ,_, likely_RB involved_VBN in_IN the_DT recruitment_NN of_IN membrane_NN proteins_NNS for_IN targeting_VBG to_TO the_DT internal_JJ vesicles_NNS ._SENT In_IN contrast_NN ,_, MG132_JJ cell_NN profiles_NNS showed_VBD no_DT or_CC few_JJ MVBs_NNS with_IN scarce_JJ mLRP4_NN labeling_VBG ._SENT Instead_RB ,_, mLRP4_NN was_VBD found_VBN intensely_RB in_IN long_JJ peripheral_JJ tubules_NNS ,_, probably_RB representing_VBG early_JJ endosomes/recycling_NN tubules_NNS (_( Figure_NP E_NP )_) ._SENT Figure_NP 8_CD |_SYM Proteasome_JJ inhibitors_NNS increase_NN surface_NN localization_NN of_IN mLRP4_NN and_CC block_VB the_DT delivery_NN of_IN mLRP4_NN into_IN MVBs_NP ._SENT Proteasome_JJ inhibitors_NNS increase_NN surface_NN localization_NN of_IN mLRP4_NN and_CC block_VB the_DT delivery_NN of_IN mLRP4_NN into_IN MVBs_NP ._SENT Cryosections_NNS of_IN CHO-mLRP4_NP cells_NNS were_VBD immunogold_NN labeled_VBN with_IN anti-HA_NN antibodies_NNS and_CC 10_CD nm_NN gold_NN particles_NNS ._SENT (_( A_NP ,_, C_NP ,_, and_CC D_NP )_) control_NN cells_NNS ;_: (_( B_NP and_CC E_NP )_) MG132-treated_JJ cells_NNS ._SENT In_IN control_NN cells_NNS (_( A_NP )_) by_IN far_RB the_DT majority_NN of_IN mLRP4_NN at_IN the_DT plasma_NN membrane_NN is_VBZ present_JJ in_IN clathrin-coated_JJ pits_NNS ,_, whereas_IN in_IN cells_NNS treated_VBN with_IN MG132_NP (_( B_NP and_CC E_NP )_) label_NN is_VBZ also_RB present_JJ outside_IN the_DT pits_NNS ._SENT (_( C_NP and_CC D_NP )_) MVBs_NP in_IN control_NN cells_NNS with_IN label_NN present_NN at_IN the_DT limiting_VBG membrane_NN and_CC associated_VBN with_IN the_DT internal_JJ vesicles_NNS ._SENT Note_VB the_DT thick_JJ clathrin_NN lattices_NNS at_IN the_DT limiting_VBG membrane_NN (_( arrows_NNS )_) ._SENT (_( E_LS )_) Peripheral_JJ cytoplasm_NN of_IN a_DT MG132-treated_JJ cell_NN with_IN labeled_VBN clathrin-coated_JJ vesicles_NNS and_CC long_JJ recycling_NN tubules_NNS (_( arrowheads_NNS )_) ._SENT All_DT bars_NNS represent_VBP 200_CD nm_NN ._SENT Residues_NNS 60_CD --_: 78_CD of_IN the_DT LRP_NP Tail_NP Are_NP Required_NP for_IN Proteasomal_NP Regulation_NP |_SYM To_TO begin_VB to_TO identify_VB cis-elements_NNS within_IN the_DT LRP_NP tail_NN that_WDT are_VBP required_VBN for_IN proteasomal_JJ regulation_NN ,_, we_PP examined_VBD the_DT effects_NNS of_IN MG132_JJ treatment_NN on_IN CHO_NP LRP-null_NP cells_NNS stably_RB expressing_VBG various_JJ tail-truncation_NN mutants_NNS of_IN mLRP4_NN ._SENT As_IN seen_VBN in_IN Figure_NP A_NP ,_, upon_IN MG132_JJ treatment_NN increase_NN of_IN cell_NN surface_NN mLRP4_NN was_VBD nearly_RB abolished_VBN when_WRB the_DT tail_NN is_VBZ truncated_VBN to_TO 59_CD amino_NN acid_NN residues_NNS but_CC not_RB when_WRB truncated_VBN to_TO 78_CD amino_NN acids_NNS ._SENT To_TO examine_VB whether_IN these_DT differences_NNS in_IN response_NN to_TO MG132_NP also_RB apply_VB to_TO the_DT steady_JJ state_NN levels_NNS of_IN these_DT truncated_JJ minireceptors_NNS ,_, we_PP compared_VBD their_PP$ steady_JJ state_NN levels_NNS in_IN the_DT absence_NN or_CC presence_NN of_IN MG132_JJ treatment_NN ._SENT As_IN seen_VBN in_IN Figure_NP B_NP ,_, each_DT of_IN these_DT mLRP4_JJ minireceptors_NNS is_VBZ expressed_VBN at_IN a_DT similar_JJ basal_JJ level_NN when_WRB the_DT precursor_NN forms_NNS are_VBP compared_VBN ._SENT The_DT increased_VBN ratios_NNS of_IN mature_JJ to_TO precursor_NN forms_NNS for_IN mLRP4Tailess_JJ and_CC mLRP4T59_NN when_WRB compared_VBN with_IN that_IN of_IN mLRP4T100_NN are_VBP due_JJ to_TO the_DT slower_JJR endocytosis_NN rates_NNS mediated_VBN by_IN these_DT two_CD truncated_JJ minireceptors_NNS ._SENT More_RBR importantly_RB ,_, we_PP demonstrated_VBD that_IN the_DT proteasome_JJ inhibitor_NN MG132_NP increased_VBD the_DT steady_JJ state_NN levels_NNS of_IN the_DT mature_JJ forms_NNS of_IN mLRP4T78_NN and_CC mLRP4T100_NN but_CC not_RB those_DT of_IN mLRP4Tailess_JJ and_CC mLRP4T59_JJ ._SENT These_DT results_NNS together_RB suggest_VBP that_IN the_DT region_NN of_IN the_DT tail_NN between_IN amino_NN acids_NNS 60_CD and_CC 78_CD may_MD contain_VB an_DT important_JJ sequence_NN or_CC binding_JJ site_NN that_IN when_WRB present_NN contributes_VBZ to_TO mLRPs_NNS regulation_NN by_IN the_DT proteasome_NN ._SENT Additionally_RB ,_, because_IN mLRP4T59_NN still_RB exhibits_VBZ significant_JJ endocytosis_NN ,_, but_CC is_VBZ minimally_RB regulated_VBN by_IN the_DT proteasome_NN ,_, the_DT re_NN 